Fig. 3: Bayley scales fine motor and gross motor raw scores. | Nature Medicine

Fig. 3: Bayley scales fine motor and gross motor raw scores.

From: Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

Fig. 3: Bayley scales fine motor and gross motor raw scores.The alternative text for this image may have been generated using AI.

Improvements were observed in all children for both gross (a) and fine (b) subtests of the Bayley Scales of Infant and Toddler Development after onasemnogene abeparvovec infusion and up to 24 months of age. The gray shading represents Bayley-III gross and fine motor normal ranges (±2 s.d.). n = 6 males and n = 9 females; mean (s.d.) age at dosing, 28.7 (11.68) days.

Back to article page